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1. Introduction 
Desulphovibrio gigas ferredoxin is active in the 
transfer of electrons in the phosphoroclastic reaction 
as well as in the transfer of electrons from molecular 
hydrogen, via hydrogenase and cytochrome c3, to 
the reduction of sulphite [ 1,2] . As shown in fig.1 the 
electrons are transferred at very different potentials 
for each of the reactions. 
After a complete purification of D. gigas 4.iron- 
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Fig. 1. Two relevant electron pathways in Desulphovibrio sp., 
the phosphoroclastic reaction and sulphite reductase system. 
The central role of cytochrome cs and the coupling effect of 
ferredoxin are schematized. Since the trithionate pathway, 
which involves the existance of sulphur intermediates during 
the reduction of sulphite to sulphide [ 161, is still under 
controversy, the global value of g’, from SO:- to S*- is given 
here. This value has been computed from the data in [ 17-201. 
Abbreviations: PDH, pyruvate dehydrogenase; Cyt cl, 
cytochrome cJ (4 haems); Fd, (4 Fe, 4 S) ferredoxin; Hase, 
hydrogenase 3x (4 Fe, 4 S). 
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4-sulphur ferredoxin, 3 distinct oligomeric forms of 
this protein were isolated [3] . These are 2 trimers 
(FdI and FdI’) with different isoelectric points, and 
1 tetramer (FdII). Each oligomer has the same 
monomer unit with mol. wt 6000, a single (4 Fe, 4 S) 
cluster and the same amino acid composition. The 
stabilization of ferredoxin in oxidation states with 
different redox potentials is controlled by modifica- 
tions brought about by the oligomerization of the 
protein. This paper shows that the constraints imposed 
by the oligomerization of this metalloprotein stabilize 
different oxidation states for each oligomer [4,5] 
and that this is an important factor in determining 
their differentiated physiological activity. 
2. Materials and methods 
The 3-oligomeric forms of D. gigas ferredoxin were 
isolated and purified as in [3] . 
The pyruvate dehydrogenase activity and the 
coupling effect of the ferredoxin oligomeric forms 
was determined by measuring the hydrogen evolution 
by a manometric assay in the following conditions: 
Main compartment: 150 pmol phosphate buffer 
(pH 7.0), 100 ~01 electron carrier (Fd), pure 
hydrogenase, 4 nmol CoA, 5 ~01 TPP, 20 pmol 
QMg, 10 mmol mercaptoethanol and the pyru- 
vate dehydrogenase containing extract in final 
vol. 3.0 ml. 
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Side arm: 30 ~01 sodium pyruvate. 
Centre well: 0.05 ml 10 M NaOH. 
The flasks were incubated for 30 min at 37°C. 
The pyruvate dehydrogenase containing extract, 
devoided of ferredoxin and flavodoxin was obtained 
by passing the D. gigas acidic extract [2] (10 ml 
containing 30 mg/ml protein) on a small DEAE 
column (10 X 10 mm) equilibrated with 0.01 M Tris- 
HCl, pH 7.6. Of this extract, 27.7 mg were used in 
all the assays performed. Pure hydrogenase prepared 
from D. gigas as in [6] with spec. act. 30 pmol 
hydrogen consumed/min/mg protein and was added 
in all cases to the system to ensure an excess of this 
activity. 
3. Results and discussion 
Physico-chemical characterization, using visible 
spectroscopy [3], NMR and magnetic susceptibility 
[4] and in particular EPR [5] , have shown that the 
3 forms stabilize the (4 Fe, 4 S) cluster in different 
oxidation states of the ‘three state hypothesis’ [7] . 
Fdl stabilizes almost exclusively the C*-/C3- states 
(E, = -455 mV), FdII stabilizes almost exclusively 
the C-/C*- states (Ec = - 130 mV). FdI’ has an 
intermediate behaviour and will not be discussed 
here. 
We have shown (see fig.3, in [3] ) that FdII is more 
efficient than FdI in the reduction of sulphite. The 
tetramer FdII utilizes oxidation states more positive 
than those normally available for bacterial ferredoxins 
and is then more efficient in accepting electrons from 
cytochrome c3. 
Figure 2 shows that in the phosphoroclastic reac- 
tion (see fig.1) it is the trimer FdI which is more 
active in the transfer of electrons between pyruvate 
and molecular hydrogen, as it should be expected 
since only the C*-/C3- redox states have the necessary 
redox potential to be active in the indicated pathway 
at ~-600 mV to -400 mV. There is a lag phase after 
which the tetrameric form FdII starts to be active in 
the transport of electrons from pyruvate. The decrease 
of activity during this lag phase, as compared to the 
endogenous, is proportional to the initial concentra- 
tion of FdII, suggesting that FdII blocks the transfer 
of electrons in this pathway. The inhibition may be 
due to the complexation of cytochrome c3 by FdII 
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Fig.2. The pyruvate dehydrogenase activity and the coupling 
effect of the ferredoxin oligomeric forms. For sake of com- 
parision, Fd concentrations are calculated per monomeric 
unit: (0) control (initial system); (A) the pyruvate dehydrog- 
enase-containing extract, devoided of electron carriers, plus 
100 nmol D. gigas FdI; (0) the pyruvate dehydrogenase 
containing extract, devoided of electron carriers, plus 100 
nmol of D. gigas FdII; (=) endogenous activity measured on 
the pyruvate dehydrogenase containing extract devoided of 
electron carriers; (0) control without pyruvate. 
[8]. One possible explanation for the increase in 
activity after the initial lag phase is that the tetrameric 
form FdII is converted into the trimeric form FdI. 
This is supported by the fact that conversion of the 
tetramer to the trimer is made possible by reconsti- 
tuting the apoprotein obtained from the tetrameric 
form [5]. However, even after the lag phase the 
activity for the same monomeric concentration is not 
fully recovered since the slope of the FdII curve is 
smaller than that of the FdI curve. 
Flavodoxin can substitute for ferredoxin in the 
above reactions [ 1,9] . The redox potentials of the 
2 available redox couples [lo] of flavodoxin, Fld/ 
FldH’ (-150 mV) and FldH/FldH* (-440 mV) [ 111, 
are strikingly similar to those of FdII and FdI, suggest- 
ing that flavodoxin uses the 2 available redox couples 
in coupling the hydrogenase to the sulphite reductase 
and in the phosphoroclastic reaction respectively. 
The 4-irona-sulphur cluster can use a wide range 
of redox potentials. This was tentatively explained by 
the ‘three state hypothesis’ which attributed this 
difference in potentials to the fact that different 
proteins utilize different oxidation states of the cluster. 
Our work, as well as [ 121 shows that the redox 
Volume 89, number 1 FEBS LETTERS May 1978 
potential of the (4 Fe, 4 S) cluster is not exclusively 
determined by the oxidation state. The structure of 
the protein plays an important role in the control of 
the cluster redox potential suggesting that a different 
‘entatic state’ [ 13,141 is created. In D. gigas ferre- 
doxin the quaternary structure modifications change 
the physico-chemical properties of the protein with 
important phyisiological consequences. Also, the great 
versatility of the (4 Fe, 4 S) cluster may be useful to 
understand the mechanism of action of more complex 
(4 Fe, 4 S) proteins, e.g., hydrogenase, for which a 
wide range of redox potentials have been observed 
[151. 
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